Skip to content

Subscriptions are live.

Plans
Logo

Why is $LYEL stock down today?

Lyell Immunopharma, Inc. Common Stock · Pharmaceutical Preparations

Why is $LYEL down today?

The likely driver

Clinical / FDA update
Lyell Immunopharma Completes Manufacturing Transfer for LYL273 and Provides Updated Timeline on Phase 1/2 Trial in
SEC filing · Sep 10
Price
$8.57
Move today
-0.2%
Volume vs avg
0.0x
Scanner alerts today
0
Flagged in 30 days
18
Market cap
$211M
Prev close
$8.59
Avg volume
146K

Nothing has triggered on LYEL yet in this session. Our scanner has flagged it 18 times in the last 30 days , most recently on October 5 for big percentage moves, unusual volume, which is why this page is here. See the full LYEL page for the chart and the alert history.

Earlier scanner activity on LYEL

  • Oct 5Unusual volume (RVOL) alert
  • Oct 5Unusual volume (RVOL) alert
  • Oct 5Unusual volume (RVOL) alert
  • Oct 5Unusual volume (RVOL) alert
  • Sep 22Unusual volume (RVOL) alert
  • Sep 21Big % mover alert
  • Sep 21Big % mover alert
  • Sep 21Unusual volume (RVOL) alert
  • Sep 15Unusual volume (RVOL) alert
  • Sep 14Unusual volume (RVOL) alert
  • Sep 14Big % mover alert
  • Sep 14Unusual volume (RVOL) alert

Prior sessions in the last 30 days. A name our scanner keeps flagging is behaving differently from the rest of the market, even on a quiet day.

Free alerts

Get free $LYEL alerts the moment volume spikes

Be first to know when $LYEL makes an unusual move. Create a free account to track $LYEL, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.

Real-time RVOL & momentum alerts Personal watchlist & price alerts
Sign up free with email

No card · 5 premium days · join 800+ traders

Other stocks moving today

Each opens that stock’s own why-is-it-moving page.

Move and volume are based on the latest market data and refresh live on this page. Scanner alerts are our own real-time unusual-volume signals. This is research, not investment advice.